About GlycanTrigger project
GlycanTrigger is a project funded by the European Union within the Horizon Europe Research and Innovation Actions, bringing together 9 organisations from 6 different European countries and 1 non-European country (USA).
In GlycanTrigger, we will investigate when, why and how changes in gut glycome trigger health-to-chronic inflammation transition. The project started in January 2023 and will be developed for 6 years under the coordination of Instituto de Investigação e Inovação em Saúde (i3S) from the University of Porto, Portugal. The GlycanTrigger consortium includes representatives from medical universities and research centers, clinical centers, one biotechnology company, one consultancy company, and one European patients’ association.
Key Numbers
Budget
6.8 M€
Duration
72 months
9 partners
6 European countries
1 USA
Diseases
Crohn’s disease (CD)
Ulcerative Colitis (UC)
News & Events
We are hiring: Research Technician
The GlycanTrigger Project is hiring a Research Technician to join the team at i3S - Institute of Health Innovation and Research. The selected candidate will be involved in [...]
New scientific publication – Immune regulatory networks coordinated by glycans and glycan-binding proteins in autoimmunity and infection
Salomé S. Pinho, Inês Alves, and Joana Gaifem, who are part of the GlycanTrigger team from i3S - Instituto de Investigação e Inovação em Saúde, collaborated with Gabriel Rabinovich [...]
